Transcendent Capital Group »

Vertex Pharmaceuticals Incorporated shares owned by Transcendent Capital Group

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Transcendent Capital Group from 13F filings

Historical chart of Transcendent Capital Group investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Transcendent Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Transcendent Capital Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $133k 326 406.89
2023-12-31 $133k 326 406.89

More positions owned by Transcendent Capital Group

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Large-cap Etf Large Cap Etf (VV)
Spdr Gold Shares Gold Shs (GLD)
First Trust Etf Iv First Trust Enhanced Short First Tr Enh New (FTSM)
Ishares Tr Cohen Steer Reit Cohen Steer Reit (ICF)
Ishares Tr Core S&p500 Etf Core S&p500 Etf (IVV)
Vanguard Real Estate Etf Real Estate Etf (VNQ)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Short-term Corporate Bond Etf Shrt Trm Corp Bd (VCSH)
Vanguard Short-term Treasury Etf Short Term Treas (VGSH)
Pacer Us Small Cap Cash Cows 100 Etf Pacer Us Small (CALF)
Invesco Nasdaq 100 Etf Nasdaq 100 Etf (QQQM)
Vanguard Intermediate-term Corporate Bond Etf Int-term Corp (VCIT)
Ishares Tr S&p 100 Etf S&p 100 Etf (OEF)

View all positions for Transcendent Capital Group

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated